Cite

HARVARD Citation

    Xu, H. et al. (2023). Oral cyclodextrin supramolecular for ulcerative colitis treatment through macrophages targeting / ROS response-based accurate on-demand drug release strategy. Materials & design. p. . [Online]. 
  
Back to record